Professional Documents
Culture Documents
Synthesis and structural characterization of 10 -(diphenylphosphino)ferrocene-1carboxamide, its corresponding hydrazide, some heterocycles derived from the
hydrazide and palladium(II) complexes with these functional phosphinoferrocene
ligands
e
pni
Petr St
cka*, Hana Solarov, Ivana Csarov
Department of Inorganic Chemistry, Faculty of Science, Charles University in Prague, Hlavova 2030, 12840 Prague, Czech Republic
a r t i c l e i n f o
a b s t r a c t
Article history:
Received 29 July 2011
Received in revised form
22 August 2011
Accepted 23 August 2011
Two polar phosphinoferrocene ligands, 10 -(diphenylphosphino)ferrocene-1-carboxamide (1) and 10 (diphenylphosphino)ferrocene-1-carbohydrazide (2), were synthesized in good yields from 10 -(diphenylphosphino)ferrocene-1-carboxylic acid (Hdpf) via the reactive benzotriazole derivative, 1-[10 (diphenylphosphino)ferrocene-1-carbonyl]-1H-1,2,3-benzotriazole (3). Alternatively, the hydrazide was
prepared by the conventional reaction of methyl 10 -(diphenylphosphino)ferrocene-1-carboxylate with
hydrazine hydrate, and was further converted via standard condensation reactions to three phosphinoferrocene heterocycles, viz 2-[10 -(diphenylphosphino)ferrocen-1-yl]-1,3,4-oxadiazole (4), 1-[10 (diphenylphosphino)ferrocen-1-carbonyl]-3,5-dimethyl-1,2-pyrazole (5), and 1-[10 -(diphenylphosphino)
ferrocene-1-carboxamido]-3,5-dimethylpyrrole (6). Compounds 1 and 2 react with [PdCl2(cod)]
(cod h2:h2-cycloocta-1,5-diene) to afford the respective bis-phosphine complexes trans-[PdCl2(L-kP)2]
(7, L 1; 8, L 2). The dimeric precursor [(LNC)PdCl]2 (LNC 2-[(dimethylamino-kN)methyl]phenyl-kC1)
is cleaved with 1 to give the neutral phosphine complex [(LNC)PdCl(1-kP)] (9), which is readily transformed into a ionic bis-chelate complex [(LNC)PdCl(1-k2O,P)][SbF6] (10) upon removal of the chloride
ligand with Ag[SbF6]. Pyrazole 5 behaves similarly affording the related complexes [(LNC)PdCl(5-kP)] (12)
and [(LNC)PdCl(5-k2O,P)][SbF6] (13), in which the ferrocene ligand coordinates as a simple phosphine and
an O,P-chelate respectively, while oxadiazole 4 affords the phosphine complex [(LNC)PdCl(4-kP)] (11) and
a P,N-chelate [(LNC)PdCl(4-k2N3,P)][SbF6] (14) under similar conditions. All compounds were characterized by elemental analysis and spectroscopic methods (multinuclear NMR, IR and MS). The solid-state
structures of 1,AcOEt, 2, 7,3CH3CN, 8,2CHCl3, 9,CH2Cl2,0.375C6H14, 10, and 14 were determined
by single-crystal X-ray crystallography.
2011 Elsevier B.V. All rights reserved.
Keywords:
Ferrocene
Phosphine ligands
Amides
Heterocycles
Palladium complexes
Structure elucidation
1. Introduction
While exploring the synthetic potential [1], coordination
chemistry and catalytic properties [2,3] of N-substituted phosphinoferrocene carboxamides, we realized that the corresponding
archetypal compounds, namely the primary amide and hydrazide
derivatives, remain still unknown. Actually, such derivatives
are quite rare even among compounds derived from simple
organic phosphinocarboxylic acids. Whereas the primary phosphinocarboxylic amides are rather scarce [4], the respective
3728
PPh 2
PPh 2
Fe
Fe
O
CO2H
C
NH
1 (Y = H)
Hdpf
2 (Y = NH 2)
Scheme 1.
PPh2
Fe
O
C
NH2
PPh 2
PPh 2
NH3
HC(OEt) 3
Fe
Fe
PPh2
MeSO2Bt
Fe
Fe
PPh2
N
NHNH 2
N
CO 2H
C
3
Hdpf
CH2N2
MeCOCH 2 CH 2 COMe
MeCOCH 2 COMe
NH2NH2
PPh 2
PPh 2
Fe
PPh2
NH2NH2
Fe
Fe
Me
C
NH
C
OCH3
O
C
O
Medpf
Fe
PPh2
C
2
NHNH2
Me
5
Me
6
Me
m/z 321, and [Ph2PO] at m/z 201). Similar features have been
observed in the EI MS spectra of Hdpf and Medpf [12].
1
H and 13C{1H} NMR spectra of 1-6 displayed characteristic
signals of the 10 -substituted (diphenylphosphino)ferrocenyl
moiety. The spectra of 1 and 2 further comprised signals of the NH
protons while those of 3-6 showed diagnostic resonances due to
the heterocyclic substituents (4: oxadiazole CH proton at dH 8.31,
oxadiazole CH and C at dC 151.93 and 166.53, respectively; 5: methyl
resonances at dH 2.26 and 2.57/dC 13.93 and 14.66; pyrazole CH at dH
5.98/dC 110.37, and pyrazole C-Me at dC 144.35 and 151.12; 6:
equivalent CH3 groups at dH 2.10/dC 11.56; pyrrole CH at dH 5.49/dC
103.98, and pyrrole C-Me at dC 127.75). Finally, the 31P NMR signals
of 1-6 were seen in a narrow range dP 17.9 O 16.9 ppm, which is
close to that of the parent Hdpf (dP 17.6 ppm [6a]).
The solid-state structures of 1 and 2 have been determined by
single-crystal X-ray crystallography. As indicated above, the amide
was isolated in the form of the stable solvate 1,AcOEt. It crystallizes as a racemic twin with the symmetry of the chiral space
group P21 and four molecules of the amide [13] and two heavily
disordered solvent molecules per the asymmetric unit. A view of
molecule 1 in the structure is presented in Fig. 1. Because the
structure determination is of a relatively lower precision owing to
a poor quality of the available crystals (defects, disordered solvent,
twinning), the discussion of molecular geometry (Table 1) will be
restricted only to selected relevant parameters.
3729
Table 1
Selected distances and angles for 1,AcOEt (in and deg).a
Parameter
Molecule 1
Molecule 2
Molecule 3
Molecule 4
FeeCgC
FeeCgP
tilt
1.638(4)
1.646(4)
2.9(5)
142
1.26(1)
1.34(1)
119.9(8)
7(1)
1.649(4)
1.652(4)
4.7(6)
79
1.25(1)
1.33(1)
120.9(8)
9(1)
1.652(4)
1.654(4)
2.9(6)
140
1.27(1)
1.34(1)
119.6(8)
5(1)
1.642(4)
1.645(4)
6.3(6)
81
1.25(1)
1.36(1)
120.3(8)
9(1)
s
C]O
CeNH2
OCeNH2
f
Fig. 1. (a) View of molecule 1 in the crystal structure of solvated amide 1 showing
displacement ellipsoids scaled to 30% probability. (b) Hydrogen bonding interactions in
the structure of 1. For clarity, only the amide-substituted cyclopentadienyl rings and
NH hydrogens are shown. The circled numbers are used to distinguish the four crystallographically independent molecules.
Denitions: CgC and CgP are the centroids of the amide- and PPh2-substituted
cyclopentadienyl rings, respectively; tilt dihedral angle of the cyclopentadienyl
least-squares planes; s torsion angle C(n01)eCgCeCgPeC(n06) (n indicates the
molecule); f dihedral angle subtended by the amide moiety (CON) and the plane
of its parent cyclopentadienyl ring.
3730
YNH
C
Ph
Ph
P
[PdCl2 (cod)] + 2L
O
Cl
Fe
Pd
- cod
Fe
Cl
O
Ph
Ph
C
HNY
7 (L = 1, Y = H)
8 (L = 2, Y = NH2)
Scheme 4. Synthesis of palladium(II) bis-phosphine complexes (cod cycloocta-1,5diene).
Fig. 2. (a) View of the molecule of hydrazide 2 showing 30% probability displacement
ellipsoids. Selected distances and angles (in and deg): FeeCgC 1.6466(8), FeeCgP
1.6431(8), :CpC,CpP 1.7(1); C11eO 1.237(2), C11eN1 1.337(2), N1eN2 1.413(2), PeC6
1.817(2), PeC12 1.838(2), PeC18 1.836(2); OeC11eN1 121.4(2), C11eN1eN2 121.2(1).
(b) Hydrogen bonding interactions in the structure of 2. For clarity, only pivotal atoms
from the phenyl rings are shown. The possible NeH,,,lone pair(P) interaction is
indicated by a dotted arrow. Hydrogen bond parameters: N1eH1N,,,O,
N1,,,O 2.772(2) , angle at H1N 166 ; C2eH2,,,O, C2,,,O 3.349(2) , angle at
H2 147 ; P,,,H3N z 2.93 .
Fig. 3. (a) View of the complex molecule in the crystal structure of 7,3CH3CN.
Displacement ellipsoids enclose the 30% probability level. (b) Hydrogen bonding
interactions in the structure of 7,3CH3CN. For clarity, only the pivotal atoms from the
phenyl rings, amide hydrogens and relevant solvent molecules are shown.
Fig. 4. (a) View of the complex molecule in the crystal structure of 8,2CHCl3.
Displacement ellipsoids correspond to 30% probability. (b) Hydrogen bonding interactions in the structure of 8,2CHCl3. For clarity, only the pivotal atoms from the phenyl
rings and NH hydrogens are shown, and the solvent molecules are omitted. The
N2eH3N,,,O contact has an unfavorable geometry (angle at H3N 112 ).
3731
N
Pd
Table 2
Selected distances and angles for 7,3CH3CN and 8,2CHCl3 (in and deg).a
Parameter
PdeCl
PdeP
ClePdeP
FeeCgC
FeeCgP
tilt
s
C]O
CeN
OCeN
7,3CH3CN
8,2CHCl3
Molecule 1
Molecule 2
2.2830(8)
2.3462(7)
86.70(3)
1.648(2)
1.645(1)
5.3(2)
95
1.235(4)
1.342(4)
122.1(3)
6.3(4)
2.2859(8)
2.3293(7)
92.93(3)
1.653(1)
1.650(1)
4.3(2)
146
1.238(4)
1.332(4)
122.2(3)
14.6(3)
Cl
2
1
2.301(2)
2.358(2)
95.07(6)
1.648(3)
1.647(3)
1.8(4)
134
1.240(8)
1.316(8)
121.9(6)
19.9(7)
a
CgC and CgP are the centroids of amide- and PPh2-substituted cyclopentadienyl
rings, respectively. s torsion angle C1eCgCeCgPeC6; f dihedral angle subtended
by the amide (CON) plane and its bonding cyclopentadienyl ring.
b
Further data: N1eN2 1.439(8) , C11eN1eN2 121.3(5) .
Ph
Ph
Ph
P
Pd
Fe
Cl
O
C
NH2
SbF6
Ph
AgSbF6
- AgCl
Pd
Fe
O
C
NH2
10
Scheme 5. Synthesis of palladium(II) complexes with amide 1 and 2-[(dimethylamino-kN)methyl]phenyl-kC [1] (LNC) supporting ligand.
3732
and NCH2 groups and four multiplets due to protons at the palladated benzene ring. The values of 4JPH coupling constants suggested
trans-PeN relationship [23] in both cases. It is noteworthy that the
ferrocene protons were observed degenerate in the spectra of both
compounds (four signals due to AA0 BB0 and AA0 BB0 X spin systems;
A, B 1H, X 31P), suggesting that conformational exibility is
maintained even after closure of the O,P-chelate ring [24]. The 31P
NMR signals were seen shifted to lower elds as compared with the
free ligand (coordination shifts: DP 49.3 ppm for 9, and 46.8 ppm
for 10), signicantly more than for the bis-phosphine complex 7
(DP 33.7 ppm). The coordination of the amide oxygen was
inferred from IR spectra, where one of two strong amide signals
around 1600 cm1 (1644 and 1607 cm1 for 1, 1655 and 1604 for 9)
appeared shifted to lower energies in 10 (1655 and 1568 cm1).
The crystal structures of 9,0.5CH2Cl2,0.375C6H14 and 10 have
been determined by single-crystal X-ray diffraction analysis. Views
of the molecular structures are presented in Fig. 5. Selected
geometric data are given in Table 3. Compound 9 crystallizes with
two molecules of the complex, one molecule of solvating CH2Cl2
and disordered hexane with a fractional occupation in the asymmetric part of the unit cell. The independent complex molecules
differ mainly in conformation, mostly in the carbamoylferrocenyl
moiety.
The individual geometric parameters determined for 9 and 10
are rather unexceptional and do not differ much from those
reported earlier for [(LNC)PdCl(Ph2PfcCONHCH2CO2Me-kP)] [2 g]
and [(LNC)Pd(Ph2PfcCONHR-k2O,P)]X (R/X Ph/SbF6 [2m] and
CH2CO2Me/ClO4 [2 g]). The coordination environments around the
palladium atoms in 9 and 10 are markedly distorted, very likely due
to a combination of unlike Pd-donor bond distances, steric
demands of the donor moieties and the presence of a relatively
small and rigid palladacycle (N.B. The CePdeN angle is the most
acute among the interligand angles). The most severely distorted is
molecule 1 in the structure of 9, which exerts a considerable
departure from an ideal planar geometry as evidenced by the
angles
subtended
by
ligands
in
trans
positions
(Cl1ePd1eC124 156.93(9) and P1ePd1eN12 165.19(8) ) and also
by the sum of the four interligand angles (ca. 365 ). The distortion
of the coordination sphere around Pd in molecule 2 (compound 9)
is similar but less pronounced as indicated by the angles
Cl2ePd2eC224 and P2ePd2eN22 being 162.7(1) and 172.3(1) ,
respectively. Accordingly, the sum of interligand angles in molecule
Table 3
Selected distances and angles for 9,0.5CH2Cl2,0.375C6H14 and 10 (in and deg).a
Parameter
PdePb
PdeCc
PdeNd
PdeE
PePdeCb,c
PePdeEb
NePdeEb,d
NePdeCb,c,d
FeeCgC
FeeCgP
tilt
s
C]O
CeN
OCeN
9,0.5CH2Cl2,0.375C6H14
10
Molecule 1 (E Cl1)
Molecule 2 (E Cl2)
(E O)
2.2455(8)
2.004(4)
2.160(3)
2.4198(9)
93.0(1)
99.01(3)
90.16(8)
82.6(1)
1.652(2)
1.651(2)
2.6(2)
140
1.243(4)
1.337(4)
122.5(3)
8.5(4)
2.2350(9)
1.993(4)
2.150(3)
2.402(1)
94.5(1)
94.07(3)
91.7(1)
81.4(2)
1.642(2)
1.646(2)
2.3(2)
144
1.230(4)
1.345(4)
122.3(3)
2.9(4)
2.2656(6)
2.000(2)
2.141(2)
2.183(2)
92.25(6)
97.79(4)
88.78(6)
81.22(8)
1.649(1)
1.650(1)
6.0(1)
63
1.264(3)
1.329(3)
119.7(2)
24.9(2)
Denitions: CgC and CgP are the centroids of the amide- and PPh2-substituted
cyclopentadienyl rings, respectively; tilt dihedral angle of the cyclopentadienyl
least-squares planes; s torsion angle C(n01)eCgCeCgPeC(n06) (n indicates the
molecule for 9); f dihedral angle subtended by the amide moiety (CON) and the
plane of its parent cyclopentadienyl ring.
b
Pd1 and P1 for 9, molecule 1; Pd2 and P2 for 9, molecule 2; Pd and P for 10.
c
C124 for 9, molecule 1; C224 for 9, molecule 2, and C24 for 10.
d
N12 for 9, molecule 1; N22 for 9, molecule 2, and N2 for 10.
Fig. 5. The molecular structures of (a) of complex 9 (molecule 1) in the structure of 9,0.5CH2Cl2,0.375C6H14, and (b) the cation in the structure of 10. Displacement ellipsoids
enclose the 30% probability level.
3733
N
Pd
Cl
2
L=5
L=4
Ph
Ph
Ph
Pd
P
N
Cl
N
CH3
11
12
AgSbF6
AgSbF6
- AgCl
- AgCl
SbF6
Ph
Ph
SbF6
Ph
P
Pd
Fe
N
Pd
Fe
O
Fig. 6. (a) Hydrogen bonding interactions in the structure of complex 9. Only the
pivotal atoms in the phenyl rings and amide hydrogens in for molecules 1 and only the
CeCONH2 moieties from molecules 2 are shown in order to simplify the complicated
picture. (b) Hydrogen bonding interactions in the structure of complex 10. Only the
pivotal atoms from the phenyl rings and amide hydrogens are shown for clarity.
CH3
Ph
Cl
O
C
Fe
Pd
Fe
Ph
P
14
CH3
N
CH3
13
NC
3734
1
H NMR spectra conrmed the formulation of 10e14 by
showing signals due to both the phosphinoferrocene ligands and
the LNC moiety. Notably, the spectra of chelate complexes 13 and 14
recorded at 25 C were rather broad (see Supporting Information),
which suggests a limited molecular mobility. This was conrmed by
raising the temperature of measurement to 50 C whereupon the
signals became sharper, and by cooling to 0 C, which led to
a further broadening and even to a splitting of some signals due to
locked conformations which render the ferrocene and LNC protons
diastereotopic [24]. This behavior, not observed for analogous
complex of amide 1, apparently results from steric interactions of
the bulky heterocyclic donor groups. 31P NMR signals of 10e14
were seen at positions similar to those of 9 and 10.
View of the complex cation in the structure of 14 is shown in
Fig. 7 along with selected geometric data. The observed PdeN2,
PdeP and PdeC24 distances are similar to those found for 10. The
PdeN53 distance is somewhat longer than a similar distance in
[PdCl2(LekN3)2], where L 2,5-bis(3,4,5-triethylphenyl)-1,2,4oxadiazole (2.006(2) ) [32], probably due to a relatively stronger
trans-inuence of the phosphine donor group [33] and steric
factors (chelate rings in the structure of 14). The interligand angles
within the chelating rings in 14 are more acute than the ideal 90 ,
the N2ePdeC24 angle being expectedly the most closed
(81.37(7) ). However, the closure of the in-ring angles is compensated by an opening of the remaining interligand angles and does
not therefore lead to any pronounced distortion of the coordination
environment around the palladium as indicated by the sum of the
interligand angles of 360 and by the angles subtended by donor
atoms in trans positions (N53ePdeC24 174.55(7) and
PePdeN2 176.93(5) ).
Ferrocene cyclopentadienyls in 14 assume an almost perfect
synperiplanar eclipsed conformation with s z 1. The oxadiazole
ring is rotated from the plane of its parent CpC ring by 36.8(2) ,
which brings its NeN edge closer to the Pd atom. Otherwise, the
geometry of the ferrocene unit remains regular with a tilt angle of
6.3(1) and practically identical Fe-ring centroid distances (FeeCgC
1.655(1) , FeeCgP 1.653(1) ).
3. Conclusions
Polar phosphinoferrocene donors, 10 -(diphenylphosphino)
ferrocene-1-carboxamide (1) and 10 -(diphenylphosphino)ferrocene-1-carbohydrazide (2), are readily accessible from 10 -(diphenylphosphino)ferrocene-1-carboxylic acid (Hdpf) in two steps. The
acid is rst converted to the reactive benzotriazole derivative 3,
which reacts smoothly with NH3 or hydrazine to afford the amide
derivatives in high yields. The hydrazide is available also by
a conventional route from 10 -(diphenylphosphino)ferrocene-1carboxylate, albeit in a considerably lower yield due to low
conversions of the starting ester. As exemplied by the synthesis of
compounds 4e6, hydrazide 2 is a convenient entry to phosphinoferrocene heterocycles, whose chemistry has been rather neglected
so far [34].
As typical hybrid ligands, compounds 1, 2, 4 and 5 coordinate to
soft Pd(II) ion preferably via their soft P-donor moiety. However,
a bidentate coordination can be readily enforced by removal of
a Pd-bound ligand (halide) to produce O,P- or N,P-chelated
complex cations depending on the type of the polar donor group
in position 10 of the ferrocene moiety (1 and 5 vs. 4). When uncoordinated, the amide and hydrazide moieties take part in hydrogen
bonding interactions, giving rise to highly variable supramolecular
arrays.
4. Experimental
4.1. Materials and methods
All syntheses were performed under an argon atmosphere and
with an exclusion of direct day light. Hdpf and Medpf [6a],
1-(methanesulfonyl)-1H-1,2,3-benzotriazole [9], [PdCl2(cod)] [35]
and [(LNC)PdCl]2 [36] were prepared according to literature procedures. Dichloromethane and chloroform were dried over anhydrous potassium carbonate and distilled. THF and (1,4-)dioxane
were dried over sodium metal and distilled under argon. Methanol,
pentane-2,4-dione and hexane-3,5-dione were freshly distilled
under argon. Anhydrous triethylamine (Fluka), acetonitrile
(Aldrich) and ethanol (Riedel-de Hen) were used as received. All
other chemicals and solvents used for crystallizations and chromatography were also used without any further purication (Fluka,
Aldrich; solvents from Lach-Ner and Penta).
NMR spectra were measured with a Varian UNITY Inova 400
spectrometer (1H, 399.95; 13C, 100.58; 31P, 161.90 MHz) at 298 K.
Chemical shifts (d/ppm) are given relative to internal tetramethylsilane (1H and 13C) or to external 85% aqueous H3PO4 (31P). The
NMR signals were assigned on the basis of a comparison with the
data reported related compounds (Hdpf and amides derived
thereof, corresponding heterocycles with organic substituents etc.).
Standard notation of the signal multiplicity is employed. In addition, vt and vq are used to denote virtual multiplets due to
magnetically non-equivalent AA0 BB0 and AA0 BB0 X spin systems of
the amide- and phosphorus-substituted cyclopentadienyl rings,
respectively (fc ferrocen-1,10 -diyl; Bt 1,2,3-benzotriazol-1-yl).
The multiplicity 13C{1H} NMR resonances are specied only for
non-singlet signals. IR spectra were recorded with an FT IR Nicolet
Magna 760 instrument in the range of 400e4000 cm1. Electrospray ionization mass spectra (ESI MS) were recorded on a Bruker
Esquire 3000 spectrometer. The samples were dissolved in
dichloromethane and diluted with methanol in a large excess. High
C29H56
23FeN3OP ([M H] ) 516.0923, found 516.0923.
4.3. Preparation of 10 -(diphenylphosphino)-1-ferrocene
carboxamide (1)
Aqueous ammonia (6 mL 25%, ca. 54 mmol) was added to
a solution of 3 (1.61 g, 3.12 mmol) dissolved in a mixture of absolute
ethanol (6 mL) and THF (12 mL). The resultant mixture was stirred
at room temperature for 3 h whereupon it turned from original red
to orange. Then, the volatiles were removed under vacuum and the
residue was dissolved in ethyl acetate. The organic extract was
washed twice with 2 M NaOH, dried (MgSO4) and evaporated. The
crude product was puried by ash chromatography (silica gel,
dichloromethaneemethanol 10:1, v/v) and subsequently crystallized by liquid-phase diffusion from ethyl acetateehexane to afford
solvate 1,AcOEt as an orange crystalline solid (1.03 g, 72%).
1
H NMR (CDCl3): d 1.25 (t, 3JHH 7.1 Hz, 1.5 H, CH3CO2CH2CH3),
2.04 (s, 1.5 H, CH3CO2CH2CH3), 4.11 (vq, J0 1.8 Hz, 2 H, fc), 4.12 (q,
3
JHH 7.1 Hz, 1 H, CH3CO2CH2CH3), 4.27 (vt, J0 2.0 Hz, 2 H), 4.46
(vt, J0 1.8 Hz, 2 H) and 4.58 (vt, J0 2.0 Hz, 2 H) (3 CH of fc); 5.47
(s, 2 H, NH2), 7.31e7.40 (m, 10 H, PPh2) ppm. 31P{1H} NMR (CDCl3):
d 16.9 (s) ppm. 13C{1H} NMR (CDCl3): d 69.95 (s, 2 C, CH fc), 71.99
(s, 2 C, CH fc), 73.05 (d, 3JPC 2 Hz, 2 C, CH fc), 74.60 (d, 2JPC 14 Hz,
2 C, CH fc), 75.23 (s, 1 C, Cipso fc), 128.35 (d, 3JPC 7 Hz, 4 C, CHm
PPh2), 128.87 (s, 2 C, CHp PPh2), 133.50 (d, 2JPC 19 Hz, 4 C, CHo
PPh2), 138.21 (d, 1JPC 7 Hz, 2 C, Cipso PPh2), 172.35 (s, 1 C, C]O)
3735
413.0632, found 413.0639. ESI MS: m/z 436 ([L Na] ), 452
([L K]). IR (Nujol): 3483 m, 3430e3250 w, 3250e3100 m,
1737 m, 1644 s, 1607 s, 1436 w, 1351 m, 1339 m, 1308 w, 1236 w,
1181 w, 1159 m, 1114 w, 1090 m, 1068 w, 1027 m, 999 w, 910 w, 890
w, 823 m, 781 m, 741 s, 695 s, 635 m, 584 w, 541 m, 515 w, 498 s,
467 w, 452 m cm1. Anal. calc. for C23H20FeNOP$AcOEt (457.3): C
65.66, H 5.29, N 3.06%; found: C 65.81, H 5.09, N 2.95%.
4.4. Preparation of 10 -(diphenylphosphino)ferrocene-1-carbo/
hydrazide (2)
4.4.1. Method A
Hydrazine hydrate (2.5 mL, 52 mmol) was added to a solution of
Medpf (412 mg, 1.0 mmol) in methanol (12 mL) and the resulting
mixture was heated at reux for 7 h. After cooling, the mixture was
diluted with water (ca. 10 mL), the volatiles (methanol) were
removed under vacuum and the aqueous residue was cooled to
4 C. The separated solid was ltered off, washed with water and
dried under vacuum. Subsequent chromatography over silica gel
with dichloromethaneemethanol (10:1, v/v) afforded two bands.
The rst, faster-eluting contained unreacted Medpf. Evaporation of
the second band afforded 2 as orange solid. Yield: 197 mg (46%, 86%
based on unrecovered Medpf).
4.4.2. Method B
Neat hydrazine hydrate (2.3 mL, 47 mmol) was introduced to
a solution of 3 (1.22 g, 2.37 mmol) in absolute ethanol (4.5 mL) and
THF (11 mL) and the mixture was stirred at room temperature for
3.5 h. The color of the mixture changed from red to orange. The
volatiles were removed under vacuum and the residue was dissolved
in ethyl acetate. The solution was washed twice with 2 M NaOH,
dried over MgSO4 and evaporated under vacuum. Subsequent ash
chromatography (silica gel, dichloromethaneemethanol 10:1, v/v)
and crystallization from ethyl acetateehexane (liquid phase diffusion) afforded analytically pure 2 as an orange crystalline solid.
Yield: 975 mg (96%).
1
H NMR (CDCl3): d 3.94 (s, 2 H, NH2), 4.10 (vq, J0 1.8 Hz, 2 H),
4.25 (vt, J0 1.8 Hz, 2 H), 4.43 (vt, J0 2.0 Hz, 2 H) and 4.57 (vt,
J0 2.0 Hz, 2 H) (4 CH of fc); 6.97 (s, 1 H, NH), 7.31e7.39 (m, 10 H,
PPh2) ppm. 31P{1H} NMR (CDCl3): d 17.2 (s) ppm. 13C{1H} NMR
(CDCl3): d 69.15 (s, 2 C, CH fc), 71.70 (s, 2 C, CH fc), 72.78 (d,
3
JPC 4 Hz, 2 C, CH fc), 74.31 (d, 2JPC 14 Hz, 2 C, CH fc), 74.72 (s, 1 C,
Cipso fc), 77.66 (d, 1JPC 7 Hz, 1 C, Cipso fc), 128.29 (d, 3JPC 7 Hz, 4 C,
CHm PPh2), 128.80 (s, 2 C, CHp PPh2), 133.46 (d, 2JPC 20 Hz, 4 C, CHo
PPh2), 138.32 (d, 1JPC 9 Hz, 2 C, Cipso PPh2), 171.18 (s, 1 C, C]O)
ppm. EI MS: m/z (relative abundance) 429 (8), 428 (27, M$), 413
(43), 412 (100, [MeNH2]), 411 (27), 395 (25, [MeNH2OH]$), 322
(14), 321 (61, [FeC5H4PPh2O]), 319 (7), 306 (7), 305 (35,
[FeC5H4PPh2]), 304 (8), 227 (9), 226 (13, [C11H7PFe]), 202 (8), 201
(51, [Ph2PO]), 183 (13, [PPh2e2H], 171 (27), 170 (20), 56 (9). HR
$
MS (EI) calc. for C23H56
21FeN2OP (M ) 428.0741, found 428.0735.
ESI MS: m/z 429 ([L H] ), 451 ([L Na]), 467 ([L K]). IR
(Nujol): 3296 s, 1622 s, 1520 m, 1316 m, 1227 w, 1263 m, 1119 w,
1031 m, 968 m, 835 m, 826 m, 744 s, 697 m, 671 w, 590 w, 569 w,
535 w, 521 w, 499 m, 446 s, 409 w cm1. Anal. calc. for C23H21FeN2OP (428.2): C 64.50, H 4.94, N 6.54%; found: C 64.43, H 4.97, N
6.49%.
3736
C29H56
28FeN2OP ([M H] ) 507.1283 found 507.1283. ESI MS: m/z
529 ([L Na]), 545 ([L K]).
4.8. Synthesis of trans-[PdCl2(1-kP)2] (7)
A solution of [PdCl2(cod)] (14.3 mg, (0.05 mmol) in MeCN/
CH2Cl2 (1/1 v/v, 5 mL) was carefully layered with a solution of
1,AcOEt (45.7 mg, 0.10 mmol) in the same mixed solvent (5 mL).
Crystallization over several days afforded red crystals, which were
ltered off, washed with MeCN/CH2Cl2 (1/1) and dried under
vacuum. Yield: 55.7 mg (95%) of 7$MeCN$1.5CH2Cl2, red-orange
crystalline solid.
1
H NMR (DMSO): d 2.07 (s, 3 H, CH3CN), 4.47 (br vt, 4 H), 4.50 (br
vt, 4 H), 4.66 (vt, J0 z 1.9 Hz, 4 H) and 4.96 (vt, J0 z 1.9 Hz, 4 H)
(4 CH of fc); 5.75 (s, 3 H, CH2Cl2), 7.06 (s, 4 H, NH2), 7.40e7.60 (m,
20 H, PPh2) ppm. 31P{1H} NMR (CDCl3): d 16.8 (s) ppm. ESI MS:
m/z 452 ([1 K]), 967/969 ([MeCl]). IR (Nujol): 3453 w, 3405 w,
3276 w, 3158 w, 1647 s, 1609 s, 1166 m, 1103 m, 1032 m, 840 m,
745 m, 696 m, 513 m, 504 m, 472 w cm1. Anal. calc. for
C46H40Cl2Fe2N2O2P2Pd$MeCN,1.5CH2Cl2 (1172.2): C 50.72, H 3.96,
N 3.59%; found: C 50.48, H 4.00, N 3.56%.
4.9. Synthesis of trans-[PdCl2(2-kP)2] (8)
A solution of 2 (42.8 mg, 0.10 mmol) in ethanol (2 mL) was
added to a chloroform solution of [PdCl2(cod)] (14.3 mg, 0.05 mmol
in 2 mL) as a top layer. Crystallization by liquid-phase diffusion over
several days afforded red crystals, which were isolated by suction,
washed with ethanol and hexane, and dried under vacuum. Yield of
8$1.2CHCl3: 33.5 mg (57%), red crystalline solid.
ESI MS: m/z 533 ([Pd(2)]), 961 ([MeCleHCl]). IR (Nujol):
3330 w, 3310 w, 3240 w, 3204 w, 3080 w, 3050 w, 1650 s, 1626 w,
1520 s, 1436 m, 1313 s, 1228 w, 1195 w, 1164 m, 1098 s, 1061 w,
1039 s, 1027 s, 999 w, 965 m, 918 w, 876 w, 847 m, 828 m, 742 s, 710
3737
3738
Table 4
Selected crystallographic data, data collection and structure renement parameters for 1,AcOEt, 2, 7,3CH3CN, 8,2CHCl3, 9,CH2Cl2,0.375C6H14, 10 and 14.a
Compound
1,AcOEt
7,3CH3CN
8,2CHCl3
Formula
M
Crystal system
Space group
a/
b/
c/
a/
b/
g/
V/3
Z
Dc/g mL1
m(Mo Ka)/mm1
Tb
Diffractions collected
Indep/obsdc diffrns
Rintd/%
Rd observed diffrns/%
R, wRd all data/%
Dr/e 3
CCDC reference no.
C23H20FeNOP
413.22
Monoclinic
P21e
9.9553(4)
23.487(1)
17.6041(9)
C23H21FeN2OP
428.24
Monoclinic
P21/c
7.9668(1)
26.2985(4)
9.6305(1)
C48H44Cl8Fe2N4O2P2Pd
1272.51
Monoclinic
P21/c
12.5183(6)
20.326(1)
9.6925(6)
90.254(3)
100.9761(9)
4116.2(4)
8
1.334
0.822
ef
24433
12326
7.3
6.94
11.16, 18.15
2.30, 0.66
823313
1980.82(4)
4
1.436
0.858
ef
41247
4545
4.0
2.93
3.73, 7.95
0.43, 0.40
823314
C52H49Cl2Fe2N5O2P2Pd
1126.90
Triclinic
Pe1
9.3183(2)
12.1979(2)
21.9283(5)
95.456(1)
99.957(1)
94.834(1)
2430.86(9)
2
1.540
1.177
0.819e0.958
47081
9588
4.79
3.37
5.24, 8.50
1.06, 0.99
823315
94.851(3)
2457.4(2)
2
1.720
1.490
ef
16432
3911
6.1
5.29
7.61, 15.18
1.13, 0.91
823316
Compound
9,0.5CH2Cl2,0.375C6H14
10
14
Formula
M
Crystal system
Space group
a/
b/
c/
a/
b/
g/
V/3
Z
Dc/g mL1
m(Mo Ka)/mm1
Tb
Diffractions collected
Indept/obsdc diffractions
Rdint/%
Rd observed diffrns/%
R, wRd all data/%
Dr/e 3
CCDC reference no.
C34.75H38.25Cl2FeN2OPPd
764.04
Monoclinic
P21/c
19.9670(1)
32.1880(5)
10.0820(3)
C32H32F6FeN2OPPdSb
889.57
Triclinic
Pe1
10.4844(2)
11.4409(2)
15.3705(2)
74.212(1)
78.370(1)
66.9530(9)
1623.11(5)
2
1.820
1.928
0.588e0.788
35094
7451
3.1
2.47
3.18, 5.94
1.08, 0.81
823318
C33H31F6FeN3OPPdSb
914.58
Monoclinic
P21/c
11.0877(5)
28.692(1)
10.5452(4)
90.8920(6)
6478.9(2)
8
1.567
1.249
0.581e0.916
77751
14806
6.8
4.30
6.12, 11.83
1.38, 1.57
823317
93.828(1)
3347.2(2)
4
1.815
1.874
0.593e0.816
56201
7696
1.78
1.90
2.14, 4.46
0.88, 0.39
823319
[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[26]
[27]
[28]
[29]
3739
3740
[35]
[36]
[37]
[38]
[39]
[40]